Agios Reports Fourth Quarter and Full Year 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Agios Pharma (AGIO) PT Lowered to $96 at H.C. Wainwright
February 24, 2022 12:27 PM ESTH.C. Wainwright analyst Michael King lowered the price target on Agios Pharma (NASDAQ: AGIO) to $96.00 (from $98.00) while maintaining a Buy rating.
... MoreAgios Pharma (AGIO) Misses Q4 EPS by 7c
February 24, 2022 7:04 AM ESTAgios Pharma (NASDAQ: AGIO) reported Q4 EPS of ($1.74), $0.07 worse than the analyst estimate of ($1.67).
For earnings history and earnings-related data on Agios Pharma (AGIO) click here.
... More